Synofit Healthcare B.V. – Trademark Portfolio

Entity Type: 98

Synofit Healthcare B.V. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SYNOPET.

Industrieweg 154 D

NL-5683 CG Best

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SYNOPET
SYNOPET
Registered 2020

Trademark Classifications

Synofit Healthcare B.V.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Synofit Healthcare B.V. have?

Synofit Healthcare B.V. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.

What trademark classes does Synofit Healthcare B.V. file in?

Synofit Healthcare B.V. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Synofit Healthcare B.V.'s most well-known trademarks?

Synofit Healthcare B.V.'s registered trademark portfolio includes well-known marks such as SYNOPET. These are among 1 currently registered trademark in the portfolio.

What is Synofit Healthcare B.V.'s trademark registration success rate?

Synofit Healthcare B.V. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.